title: Should clinicians use omalizumab for the treatment of nasal polyps?
authors.forename: Robert M
authors.initials: RM
authors.lastname: Naclerio
authors.forename: Fuad M
authors.initials: FM
authors.lastname: Baroody
authors.forename: Jayant M
authors.initials: JM
authors.lastname: Pinto
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009298:Nasal Polyps / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized